Supriya Lifescience Ltd
NSE:SUPRIYA

Watchlist Manager
Supriya Lifescience Ltd Logo
Supriya Lifescience Ltd
NSE:SUPRIYA
Watchlist
Price: 706.75 INR -0.6%
Market Cap: 56.9B INR
Have any thoughts about
Supriya Lifescience Ltd?
Write Note

Supriya Lifescience Ltd
Total Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Supriya Lifescience Ltd
Total Current Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Supriya Lifescience Ltd
NSE:SUPRIYA
Total Current Liabilities
₹768.9m
CAGR 3-Years
-19%
CAGR 5-Years
-11%
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Total Current Liabilities
₹129.2B
CAGR 3-Years
15%
CAGR 5-Years
16%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Total Current Liabilities
₹54.5B
CAGR 3-Years
0%
CAGR 5-Years
5%
CAGR 10-Years
5%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Total Current Liabilities
₹172.5B
CAGR 3-Years
5%
CAGR 5-Years
3%
CAGR 10-Years
16%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Total Current Liabilities
₹48.5B
CAGR 3-Years
2%
CAGR 5-Years
1%
CAGR 10-Years
7%
M
Mankind Pharma Ltd
NSE:MANKIND
Total Current Liabilities
₹21.2B
CAGR 3-Years
16%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Supriya Lifescience Ltd
Glance View

Market Cap
56.9B INR
Industry
Pharmaceuticals

Supriya Lifescience Ltd. supplies active pharmaceuticals ingredients (“APIs”), with a focus on research and development. The company is headquartered in Mumbai, Maharashtra. The company went IPO on 2021-12-28. The company focuses on products in various therapeutic segments, such as Anti-Histamine, Anti-Allergics, Vitamins, Anesthetics and Anti-Asthmatics. Its manufacturing facilities include delineated areas for quality check (QC); manufacturing areas with multiple clean rooms; engineering and maintenance; warehouse; materials and finished goods stores; in-house microbiological laboratory, and functional waste treatment plant. The company handles chemical reactions, such as Friedel Craft’s Acylation, Claisen Condensation, Grignard Reaction, Mannich Reaction, Ritter Reaction, Eschweiler Clark reaction, Hydrogenation, Chlorination, Bromination, Decyanation, Isocyanation, Ethoxylation, Nitration, Alkylation, Reduction, Oxidation, Etherification, Chlorosulphonation, Phosphorylation, Chiral resolution, Heterocyclic chemistry, Thermal ring expansion and Protection/Deprotection.

SUPRIYA Intrinsic Value
448.33 INR
Overvaluation 37%
Intrinsic Value
Price

See Also

What is Supriya Lifescience Ltd's Total Current Liabilities?
Total Current Liabilities
768.9m INR

Based on the financial report for Mar 31, 2024, Supriya Lifescience Ltd's Total Current Liabilities amounts to 768.9m INR.

What is Supriya Lifescience Ltd's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 5Y
-11%

Over the last year, the Total Current Liabilities growth was -20%. The average annual Total Current Liabilities growth rates for Supriya Lifescience Ltd have been -19% over the past three years , -11% over the past five years .

Back to Top